Jane Brock Selected Research

Jane Brock Research Topics

9	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2014
7	Neoplasms (Cancer) 05/2021 - 01/2010
3	Triple Negative Breast Neoplasms 01/2020 - 10/2015
2	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2021 - 09/2017
2	Ductal Carcinoma 05/2021 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2019 - 08/2014
1	Pain (Aches) 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2020
1	Fatigue 01/2018
1	Brain Neoplasms (Brain Tumor) 11/2017
1	Carcinoma (Carcinomatosis) 11/2017
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 11/2017
1	Melanoma (Melanoma, Malignant) 11/2017
1	Mesothelioma 11/2017
1	Extranodal Extension 09/2017
1	Pathologic Complete Response 11/2015
1	Lung Diseases (Lung Disease) 12/2014

4	Hormones (Hormone)IBA 01/2019 - 04/2014
4	Biomarkers (Surrogate Marker)IBA 11/2017 - 01/2010
2	Estrogen ReceptorsIBA 05/2021 - 01/2010
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	trastuzumab deruxtecanIBA 01/2022
1	atezolizumabIBA 01/2020
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 01/2019
1	ruxolitinibIBA 01/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2017
1	Hematoxylin (Haematoxylon)IBA 09/2017
1	Immune Checkpoint InhibitorsIBA 10/2016
1	Bevacizumab (Avastin)FDA Link 11/2015
1	ARQ 197IBA 10/2015
1	src-Family KinasesIBA 08/2014
1	Oncogene Proteins (Oncogene Protein)IBA 08/2014
1	Capecitabine (Xeloda)FDA Link 04/2014
1	DNA (Deoxyribonucleic Acid)IBA 01/2010
1	ParaffinIBA 01/2010
1	ErbB Receptors (EGF Receptor)IBA 01/2010